MRK
Merck & Co Inc
Price:  
129.45 
USD
Volume:  
5,176,829.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Merck Relative Valuation

-88.2%
Upside

As of 2024-02-24, the Relative Valuation of Merck & Co Inc (MRK) is 15.22 USD. This relative valuation is based on P/E multiples. With the latest stock price at 129.45 USD, the upside of Merck & Co Inc based on Relative Valuation is -88.2%.

The range of the Relative Valuation is 4.25 - 28.97 USD.

Range Selected
Trailing P/E multiples 29.5x - 36.6x 35.0x
Forward P/E multiples 23.9x - 34.4x 30.2x
Fair Price 4.25 - 28.97 15.22
Upside -96.7% - -77.6% -88.2%
129.45 USD
Stock Price
15.22 USD
Fair Price

Merck Relative Valuation - Historical P/E Data

Date P/E
2024-02-23 898.71
2024-02-22 897.39
2024-02-21 889.48
2024-02-20 884.27
2024-02-16 887.18
2024-02-15 878.51
2024-02-14 873.51
2024-02-13 870.80
2024-02-12 870.18
2024-02-09 870.94
2024-02-08 878.99
2024-02-07 884.96
2024-02-06 880.87
2024-02-05 876.01
2024-02-02 877.60
2024-02-01 877.40
2024-01-31 838.52
2024-01-30 844.63
2024-01-29 841.99
2024-01-26 838.80
2024-01-25 834.00
2024-01-24 825.33
2024-01-23 831.99
2024-01-22 829.15
2024-01-19 825.40
2024-01-18 822.97
2024-01-17 820.12
2024-01-16 822.62
2024-01-12 823.59
2024-01-11 822.20
2024-01-10 825.19
2024-01-09 822.20
2024-01-08 814.91
2024-01-05 813.80
2024-01-04 812.34
2024-01-03 796.79
2024-01-02 786.17
2023-12-29 756.87
2023-12-28 755.14
2023-12-27 749.65
2023-12-26 747.22
2023-12-22 747.71
2023-12-21 738.61
2023-12-20 731.46
2023-12-19 739.31
2023-12-18 736.18
2023-12-15 729.73
2023-12-14 735.07
2023-12-13 743.61
2023-12-12 724.52